MULTIPLE MYELOMA SCREENING PANEL Test
Welcome to DNA Labs UAE, where we offer the MULTIPLE MYELOMA SCREENING PANEL test. This test is designed to screen for multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. By detecting abnormalities in various blood and protein levels, this test can help in the early diagnosis of multiple myeloma.
Test Details
The MULTIPLE MYELOMA SCREENING PANEL test includes the following components:
- Protein electrophoresis, serum
- Immunotyping, serum
- Kappa / Lambda Light Chains Free, serum
- Immunoglobulin Profile, serum
The cost of this test is 1870.0 AED.
Sample Condition
For this test, we require a minimum of 3 mL serum from 1 SST. The sample should be shipped refrigerated or frozen to maintain its integrity.
Report Delivery
Samples should be submitted by 9 am daily, and the report will be delivered on the next working day.
Method
The MULTIPLE MYELOMA SCREENING PANEL test is conducted using capillary electrophoresis, agarose gel electrophoresis, and immunoturbidimetry techniques.
Test Type
This test specifically focuses on screening for multiple myeloma.
Doctor
This test is recommended by an oncologist, a specialist in the field of cancer.
Test Department
This test is conducted in our dedicated Test Department.
Pre Test Information
No special preparation is required before undergoing the MULTIPLE MYELOMA SCREENING PANEL test.
Test Details
The MULTIPLE MYELOMA SCREENING PANEL test is a comprehensive group of tests that help screen for multiple myeloma. The panel includes the following tests:
- Complete Blood Count (CBC): This test measures the levels of different blood cells, including red blood cells, white blood cells, and platelets. Abnormalities in these cell counts can indicate multiple myeloma.
- Blood Protein Electrophoresis: This test separates and measures the different types of proteins in the blood. In multiple myeloma, there is often an abnormal increase in a type of protein called monoclonal immunoglobulin.
- Serum Free Light Chain Assay: This test measures the levels of free light chains, which are components of immunoglobulins, in the blood. Abnormal levels of light chains can indicate multiple myeloma.
- Urine Protein Electrophoresis: This test analyzes the proteins present in the urine. In multiple myeloma, abnormal proteins called Bence Jones proteins may be detected.
- Beta-2 Microglobulin: This test measures the levels of beta-2 microglobulin, a protein found on the surface of cells. Elevated levels can indicate multiple myeloma.
- Serum Calcium: High levels of calcium in the blood can be a sign of multiple myeloma, as the cancer can cause the release of calcium from the bones.
- Creatinine: This test measures the levels of creatinine, a waste product produced by muscle metabolism, in the blood. Elevated levels can indicate kidney damage, which can occur in multiple myeloma.
It is important to note that while the MULTIPLE MYELOMA SCREENING PANEL test is a valuable tool for screening, it is not a definitive diagnostic test for multiple myeloma. If abnormalities are detected, further testing, such as a bone marrow biopsy or imaging studies, may be necessary to confirm the diagnosis.
Test Name | MULTIPLE MYELOMA SCREENING PANEL Test |
---|---|
Components | *Protein electrophoresis, serum *Immunotyping, serum*Kappa / Lambda Light Chains Free, serum*Immunoglobulin Profile, serum |
Price | 1870.0 AED |
Sample Condition | 5 mL (3 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen. |
Report Delivery | Sample Daily by 9 am; Report Next Working day |
Method | Capillary electrophoresis,Agarose Gel Electrophoresis, Immunoturbidimetry |
Test type | Multiple Myeloma |
Doctor | Oncologist |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details | The Multiple Myeloma Screening Panel is a group of tests used to screen for multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. The panel typically includes the following tests: 1. Complete Blood Count (CBC): This test measures the levels of different blood cells, including red blood cells, white blood cells, and platelets. Abnormalities in these cell counts can indicate multiple myeloma. 2. Blood Protein Electrophoresis: This test separates and measures the different types of proteins in the blood. In multiple myeloma, there is often an abnormal increase in a type of protein called monoclonal immunoglobulin. 3. Serum Free Light Chain Assay: This test measures the levels of free light chains, which are components of immunoglobulins, in the blood. Abnormal levels of light chains can indicate multiple myeloma. 4. Urine Protein Electrophoresis: This test analyzes the proteins present in the urine. In multiple myeloma, abnormal proteins called Bence Jones proteins may be detected. 5. Beta-2 Microglobulin: This test measures the levels of beta-2 microglobulin, a protein found on the surface of cells. Elevated levels can indicate multiple myeloma. 6. Serum Calcium: High levels of calcium in the blood can be a sign of multiple myeloma, as the cancer can cause the release of calcium from the bones. 7. Creatinine: This test measures the levels of creatinine, a waste product produced by muscle metabolism, in the blood. Elevated levels can indicate kidney damage, which can occur in multiple myeloma. It is important to note that the Multiple Myeloma Screening Panel is not a definitive diagnostic test for multiple myeloma. If abnormalities are detected, further testing, such as bone marrow biopsy or imaging studies, may be needed to confirm the diagnosis. |